These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27438608)

  • 1. Benign müllerian glandular inclusions in men undergoing pelvic lymph node dissection.
    Gallan AJ; Antic T
    Hum Pathol; 2016 Nov; 57():136-139. PubMed ID: 27438608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign glandular inclusion in obturator lymph node of a man treated for prostate carcinoma.
    Moreira Leite KR; Sarkis AS; Camara-Lopes LH
    Pathol Int; 2007 Jul; 57(7):454-7. PubMed ID: 17587246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma.
    Corben AD; Nehhozina T; Garg K; Vallejo CE; Brogi E
    Am J Surg Pathol; 2010 Aug; 34(8):1211-6. PubMed ID: 20631604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign glandular inclusions in para-aortic lymph nodes in women undergoing lymphadenectomies.
    Schnurr RC; Delgado G; Chun B
    Am J Obstet Gynecol; 1978 Apr; 130(7):813-6. PubMed ID: 637105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistent Isolated Tumor Cell Clusters of Infiltrating Lobular Carcinoma and Benign Glandular Inclusions of Müllerian (Endosalpingiosis) Type in an Axillary Sentinel Node: Case Report and Review of the Literature.
    Groth JV; Prabhu S; Wiley E
    Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):144-8. PubMed ID: 25203429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
    Oliva E; Amin MB; Jimenez R; Young RH
    Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature].
    Junca A; Frouin E; Irani J; Fromont G; Levillain P
    Ann Pathol; 2015 Dec; 35(6):496-501. PubMed ID: 26597142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign Müllerian inclusions coexisting with breast metastatic carcinoma in an axillary lymph node.
    Piana S; Asioli S; Cavazza A
    Virchows Arch; 2005 Apr; 446(4):467-9. PubMed ID: 15785927
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis.
    Kim HS; Yoon G; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS; Song SY
    Int J Clin Exp Pathol; 2015; 8(5):5318-26. PubMed ID: 26191233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocervicosis involving axillary lymph nodes: first case report.
    Mukonoweshuro P; McCluggage WG
    Int J Gynecol Pathol; 2014 Nov; 33(6):620-3. PubMed ID: 25272302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endosalpingiosis Is Negative for GATA3.
    White MJ; Vang R; Argani P; Cimino-Mathews A
    Arch Pathol Lab Med; 2021 Nov; 145(11):1448-1452. PubMed ID: 33571371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Alberto Briganti, Umberto Capitanio, Felix K.-H. Chun, et al. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. Eur Urol 2008;54:794-804.
    Cai T; Nesi G; Bartoletti R
    Eur Urol; 2009 Feb; 55(2):e32-3; author reply e34-5. PubMed ID: 18760527
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival.
    Bostwick DG; Qian J; Pacelli A; Zincke H; Blute M; Bergstralh EJ; Slezak JM; Cheng L
    J Urol; 2002 Sep; 168(3):1204-11. PubMed ID: 12187268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
    Hruby S; Englberger C; Lusuardi L; Schätz T; Kunit T; Abdel-Aal AM; Hager M; Janetschek G
    J Urol; 2015 Aug; 194(2):357-63. PubMed ID: 25896557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endosalpingiosis in axillary lymph nodes simulating metastatic breast carcinoma: a potential diagnostic pitfall.
    Salehi AH; Omeroglu G; Kanber Y; Omeroglu A
    Int J Surg Pathol; 2013 Dec; 21(6):610-2. PubMed ID: 24021901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
    Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Int J Urol; 2012 Jul; 19(7):645-51. PubMed ID: 22416788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign müllerian inclusions in pelvic and paraaortic lymph nodes.
    Reich O; Tamussino K; Haas J; Winter R
    Gynecol Oncol; 2000 Aug; 78(2):242-4. PubMed ID: 10926810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary Lymph Node Inclusions.
    Cimino-Mathews A
    Surg Pathol Clin; 2018 Mar; 11(1):43-59. PubMed ID: 29413659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.